Imaging Oncogene Expression

Annals of the New York Academy of Sciences

Volumn 1002, Issue , 2003, Pages 165-188

  Tian, Xiaobing ^a,c   Aruva, Mohan R ^b,c   Rao, Ponugoti S ^b,c   Qin, Wenyi ^d   Read, Paul ^b,c   Sauter, Edward R ^d   Thakur, Mathew L ^b,c   Wickstrom, Eric ^a,b,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d University of Missouri   (United States)

Author keywords

Antisense; Breast cancer; Chelators; Conjugates; Gene expression; Hybridization; Imaging; Noninvasive; Oligonucleotides; Oncogenes; Peptides; Radionucleotides; Scintigraphy; Tumors

Indexed keywords

AMINO ACID DERIVATIVE; CHELATING AGENT; COMPLEMENTARY DNA; MESSENGER RNA; PEPTIDE DERIVATIVE; PEPTIDE NUCLEIC ACID; SOMATOMEDIN C; TECHNETIUM 99M;

BIOACCUMULATION; BREAST CANCER; CANCER MORTALITY; CANCER STAGING; CHELATION; CHIMERA; CONFERENCE PAPER; CROSS COUPLING REACTION; DIAGNOSTIC ACCURACY; DNA PROBE; DNA PURIFICATION; DNA SYNTHESIS; DRUG DISTRIBUTION; GAMMA RADIATION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; ISOTOPE LABELING; MAMMOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR INTERACTION; NONHUMAN; ONCOGENE; PHYSICAL EXAMINATION; PROTEIN DNA BINDING; SCINTIGRAPHY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; XENOGRAFT;

EID: 1342332353     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1281.015     Document Type: Conference Paper

References (43)

1. SAUTER, E.R. et al. 2000. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model. Clin. Cancer Res. 6: 654-660.
2. VAUGHN, J.P. et al. 1995. Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay. Proc. Natl. Acad. Sci. USA 92: 8338-8342.
3. WICKSTROM, E. & F.L. TYSON. 1997. Differential oligonucleotide activity in cell culture versus mouse models. Oligonucleotides as Therapeutic Agents: CIBA Foundation Symposium 209: 124-137; discussion 137-141.
4. WICKSTROM, E.L. et al. 1988. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc. Natl. Acad. Sci. USA 85: 1028-1032.
5. WICKSTROM, E., T.A. BACON & E.L. WICKSTROM. 1992. Down-regulation of c-MYC antigen expression in lymphocytes of Eμ-c-myc transgenic mice treated with anti-c-myc DNA methylphosphonates. Cancer Res. 52: 6741-6745.
6. HUANG, Y. et al. 1995. Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate. Mol Med. 1: 647-658.
7. SMITH, J.B. & E. WICKSTROM. 1998. Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model. J. Natl. Cancer Inst. 90: 1146-1154.
8. BISHOP, M.R. et al. 1997. Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome. J. Hematother. 6: 441-446.
9. BAYEVER, E. et al. 1994. Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide sequences. Leuk. & Lymphoma 12: 223-231.
10. MARTIN, K.J. et al. 2000. Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res. 60: 2232-2238.
11. NAMAVARI, M. et al. 2000. Synthesis of 8-[(18)F]fluoroguanine derivatives: in vivo probes for imaging gene expression with positron emission tomography. Nucl. Med. Biol. 27: 157-162.
12. HUSTINX, R. et al. 2000. Imaging in vivo herpes simplex virus thymidine kinase gene transfer and expression in tumors using positron emission tomography. J. Nucl. Med. 41: 264P.
13. PONOMAREV, V. et al. 2000. PET imaging of p53 gene expression in tumors. J. Nucl. Med. 41: 263P-264P.
14. VINBERG, N. & K. KRISTENSEN. 1980. Fission MO-99/Tc-99m generators - a study of their performance and quality. Eur. J. Nucl. Med. 5: 435-438.
15. THAKUR, M.L. et al. 2000. Imaging vascular thrombosis with 99mTc-labeled fibrin alpha-chain peptide. J. Nucl. Med. 41: 161-168.
16. THAKUR, M.L. et al. 2000. 99mTc-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans. J. Nucl. Med. 41: 107-110.
17. PALLELA, V.R. et al. 1999. Imaging thromboembolism with Tc-99m-labeled thrombospondin receptor analogs TP-1201 and TP-1300. Thromb. Res. 93: 191-202.
18. NIELSEN, P.E., M. EGHOLM & O. BUCHARDT. 1994. Peptide nucleic acid (PNA). A DNA mimic with a peptide backbone. Bioconjugate Chem. 5: 3-7.
19. EGHOLM, M. et al. 1993. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules [see comments]. Nature 365: 566-568.
20. BUCHARDT, O. et al. 1993. Peptide nucleic acids and their potential applications in biotechnology. Trends Biotechnol. 11: 384-386.
21. GOOD, L. & P.E. NIELSEN. 1997. Progress in developing PNA as a gene-targeted drug. Antisense Nucleic Acid Drug Dev. 7: 431-437.
22. BONHAM, M.A. et al. 1995. An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers. Nucleic Acids Res. 23: 1197-1203.
23. BASU, S. & E. WICKSTROM. 1997. Synthesis and characterization of a peptide nucleic acid conjugated to a D-peptide analog of insulin-like growth factor 1 for increased cellular uptake. Bioconjugate Chem. 8: 481-488.
24. ALDRIAN-HERRADA, G. et al. 1998. A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucleic Acids Res. 26: 4910-4916.
25. TIAN, X. & E. WICKSTROM. 2002. Continuous solid-phase synthesis and disulfide cyclization of peptide-PNA-peptide chimeras. Organic Lett. 4: 4013-4016.
26. BASERGA, R. 1995. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55: 249-252.
27. ARMENGOL, G. et al. 2000. DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma. Cancer Genet. Cytogenet. 116: 133-141.
28. ANDREWS, D.W. et al. 2001. Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas. J. Clin. Oncol. 19: 2189-2200.
29. PIETRZKOWSKI, Z. et al. 1992. Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. Cancer Res. 52: 6447-6451.
30. LAL, R.B. et al. 1993. Over expression of insulin-like growth factor receptor type-I in T-cell lines infected with human T-lymphotropic virus types-I and -II. Leuk. Res. 17: 31-35.
31. MASUR, S. & P. JAYALEKSHMY. 1978. J. Am. Chem. Soc. 101: 677-683.
32. ALBERICIO, F. et al. 1991. Cyclization of disulfide-containing peptides in solid-phase synthesis. Int. J. Pept. Protein Res. 37: 402-413.
33. YAJIMA, H. et al. 1988. Tetrahedron 44: 805-819.
34. GARCIA-ECHEVARRIA, C. et al. 1993. J. Am. Chem. Soc. 115: 11663-11670.
35. KAMBER, B. et al. 1980. Helv. Chim. Acta 63: 899-915.
36. RAO, P.S. et al. 2003. Tc-99m-peptide-PNA probes for oncogene mRNAs in tumors. Nucl. Med. Commun. 24: 857-863.
37. GUVAKOVA, M.A. & E. SURMACZ. 1997. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp. Cell Res. 231: 149-162.
38. BIÈCHE, I. et al. 1999. Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res. 59: 2759-2765.
39. GRAY, G.D., S. BASU & E. WICKSTROM. 1997. Transformed and immortalized cellular uptake of oligodeoxynucleoside phosphorothioates, 3′-alkylamino oligodeoxynucleotides, 2′-O-methyl oligoribonucleotides, oligodeoxynucleoside methylphosphonates, and peptide nucleic acids. Biochem. Pharmacol. 53: 1465-1476.
40. BRANDEN, L.J., A.J. MOHAMED & C. SMITH. 1999. A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. Nat. Biotechnol. 17: 784-787.
41. CUTRONA, G. et al. 2000. Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat. Biotechnol. 18: 300-303.
42. SOOMETS, U., M. HALLBRINK & U. LANGEL. 1999. Antisense properties of peptide nucleic acids. Front. Biosci. 4: D782-D786.
43. POOGA, M. et al. 1998. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol. 16: 857-861.